Next-Generation Neurological Testing Platform

Publication ID: 24-11857349_0010_PTD
Published: October 28, 2025
Category:Future Evolutions & Paradigm Shifts

Legal Citation

pr1or.art Inc., “Next-Generation Neurological Testing Platform,” Published Technical Disclosure No. 24-11857349_0010_PTD, Published October 28, 2025, available at https://archive.pr1or.art/24-11857349_0010_PTD
This technical disclosure describes improvements that would be readily apparent to a Person Having Ordinary Skill In The Art (PHOSITA) when considered in combination with the foundational architecture disclosed in U.S. Patent No. 11,857,349.

Summary of the Inventive Concept

A comprehensive, AI-driven neurological testing system integrating wearable devices, virtual reality, and cloud-based analytics to provide personalized, real-time assessments and diagnoses.

Background and Problem Solved

The original patent disclosed a performance test system for evaluating neurological function. However, it had limitations in terms of user experience, data analysis, and scalability. The new inventive concept addresses these limitations by introducing a next-generation platform that leverages AI, machine learning, and advanced sensors to provide more accurate and personalized assessments.

Detailed Description of the Inventive Concept

The system consists of a wearable neurological testing device with a neural interface for real-time brain activity monitoring, integrated with a virtual reality platform that utilizes machine learning algorithms to adapt the testing environment to an individual's cognitive and neuromotor abilities. The system also includes a cloud-based platform for remote testing, featuring a secure data storage system and analytics engine, enabling real-time collaboration and data sharing between healthcare professionals and researchers. The modular, 3D-printed platform can be customized to accommodate various neurological and cognitive tests, and includes sensors for tracking user movements and gestures.

Novelty and Inventive Step

The new claims introduce the use of AI, machine learning, and advanced sensors to provide personalized, real-time assessments and diagnoses, which is a significant departure from the original patent's limitations. The integration of wearable devices, virtual reality, and cloud-based analytics is a novel and non-obvious combination that enables a more comprehensive and accurate evaluation of neurological function.

Alternative Embodiments and Variations

Alternative embodiments could include the use of augmented reality instead of virtual reality, or the integration of other types of sensors, such as EEG or EMG. Variations could include the development of specialized testing platforms for specific neurological disorders, or the creation of a mobile app for remote testing and data tracking.

Potential Commercial Applications and Market

The next-generation neurological testing platform has significant commercial potential in the healthcare and medical research industries, particularly in the areas of neurological disorder diagnosis and treatment. The platform's ability to provide personalized, real-time assessments and diagnoses could revolutionize the field of neurological testing, and its potential applications could extend to fields such as education and cognitive training.

CPC Classifications

SectionClassGroup
A A61 A61B5/7271
A A61 A61B3/032
A A61 A61B5/11
A A61 A61B5/112
A A61 A61B5/1124
A A61 A61B5/1125
A A61 A61B5/16
A A61 A61B5/165
A A61 A61B5/225
A A61 A61B5/4023
A A61 A61B5/4076
A A61 A61B5/4082
A A61 A61B5/4088
A A61 A61B5/162
A A61 A61B2560/04
A A61 A61B2562/0219
G G06 G06F2203/04809

Field of Art

Medical diagnostics and neurological assessment technologies, focusing on computational systems for cognitive and neurological function evaluation, with expertise in human-computer interaction, sensor integration, and diagnostic testing platforms

Person of Ordinary Skill (PHOSITA) Profile

A professional with advanced degrees in biomedical engineering, computer science, or neuroscience, possessing expertise in medical device design, machine learning applications in healthcare, and understanding of neurological assessment methodologies

Obviousness Rationale

A PHOSITA would recognize that the source patent's neurological testing apparatus provides a foundational framework that can be naturally extended through emerging technologies like AI, machine learning, and cloud-based analytics. The core diagnostic objectives remain consistent, while the implementation methods evolve to incorporate more sophisticated sensing, data processing, and personalization techniques. The PTD represents a predictable technological progression that combines known elements in a manner that would be apparent to a skilled practitioner seeking to enhance neurological testing capabilities.

Obvious Combinations & Variations

Source Patent Element
Test fixture configured to overlay a computing device's display screen for neurological performance testing
PTD Variation
Integration of virtual reality platform with neural interface and machine learning algorithms for adaptive testing environments
Obviousness Reasoning
A PHOSITA would recognize that extending a fixed testing platform to a dynamic, AI-driven environment represents a predictable technological evolution using known machine learning techniques to enhance diagnostic precision
Source Patent Element
Computing device with touch screen detection of contact members during testing
PTD Variation
Wearable device with neural interface for real-time brain activity monitoring and gesture tracking sensors
Obviousness Reasoning
Transitioning from static touch-based interaction to comprehensive physiological sensing is a logical progression using established sensor integration and data capture techniques
Source Patent Element
Performance test system for evaluating neurological function
PTD Variation
Cloud-based platform enabling remote testing, secure data storage, and collaborative analytics between healthcare professionals
Obviousness Reasoning
Extending localized testing to distributed, cloud-enabled diagnostic platforms represents a standard technological advancement in medical informatics and telemedicine
Source Patent Element
Base fixture designed for overlaying computing device screens
PTD Variation
Modular, 3D-printed platform customizable for various neurological and cognitive test configurations
Obviousness Reasoning
Adapting testing hardware for increased modularity and customization is an obvious design optimization using contemporary manufacturing and design techniques
35 U.S.C. § 103 Summary: Based on the teachings of US Patent 11857349 and the disclosed technological variations, a person having ordinary skill in the art would find the claimed neurological testing system variations obvious and anticipated, as the PTD demonstrates a predictable technological progression utilizing known techniques in AI, sensor integration, and diagnostic platform design to extend the foundational neurological assessment methodology.

Original Patent Information

Patent NumberUS 11,857,349
TitleApparatus and related method to facilitate test via a computing device
Assignee(s)THE CLEVELAND CLINIC FOUNDATION, BIOGEN MA INC.